Last Updated: September 24, 2026

Technetium tc-99m tetrofosmin kit - Generic Drug Details

Name: technetium tc-99m tetrofosmin kit Generic Launch, Drug Patent, and Exclusivity Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for technetium tc-99m tetrofosmin kit and what is the scope of patent protection?

Technetium tc-99m tetrofosmin kit is the generic ingredient in two branded drugs marketed by Medi-physics and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for technetium tc-99m tetrofosmin kit

International Patents:	8
US Patents:	1
Tradenames:	2
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	1
Clinical Trials:	1
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for technetium tc-99m tetrofosmin kit
DailyMed Link:	technetium tc-99m tetrofosmin kit at DailyMed

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for technetium tc-99m tetrofosmin kit

Generic Entry Date for technetium tc-99m tetrofosmin kit^: ⤷ Start Trial* Constraining patent/regulatory exclusivity: ⤷ Start Trial Dosage: INJECTABLE;INJECTION

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for technetium tc-99m tetrofosmin kit

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Ferozsons Laboratories Ltd.	Phase 4

See all technetium tc-99m tetrofosmin kit clinical trials

US Patents and Regulatory Information for technetium tc-99m tetrofosmin kit

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Medi-physics	MYOVIEW 30ML	technetium tc-99m tetrofosmin kit	INJECTABLE;INJECTION	020372-002	Jul 7, 2005		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial	Y			⤷ Start Trial
Medi-physics	MYOVIEW	technetium tc-99m tetrofosmin kit	INJECTABLE;INJECTION	020372-001	Feb 9, 1996		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for technetium tc-99m tetrofosmin kit

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Medi-physics	MYOVIEW	technetium tc-99m tetrofosmin kit	INJECTABLE;INJECTION	020372-001	Feb 9, 1996	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for technetium tc-99m tetrofosmin kit

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
China	101861170	Improved radiopharmaceutical composition	⤷ Start Trial
European Patent Office	2190484	COMPOSITION RADIOPHARMACEUTIQUE AMÉLIORÉE (IMPROVED RADIOPHARMACEUTICAL COMPOSITION)	⤷ Start Trial
Spain	2562441		⤷ Start Trial
United Kingdom	0718386		⤷ Start Trial
Hong Kong	1149203	IMPROVED RADIOPHARMACEUTICAL COMPOSITION	⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for technetium tc-99m tetrofosmin kit

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1178838	300736	Netherlands	⤷ Start Trial	PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Summary for technetium tc-99m tetrofosmin kit

DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for technetium tc-99m tetrofosmin kit

Recent Clinical Trials for technetium tc-99m tetrofosmin kit

Make Better Decisions: Try a trial or see plans & pricing

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for technetium tc-99m tetrofosmin kit